BofA Agents $200MM Revolver for BioMarin
BioMarin Pharmaceutical entered into a $200 million revolving credit facility with Bank of America as administrative agent and swing line lender and Citibank as L/C issuer.
November 21, 2018
Bank of America | BioMarin Pharmaceutical | Citibank
Amanda Koprowski